Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Speciallæge Jette Labianca ApS
APS
Active
CVR 43739875
Engelsborgvej 38, 1.
Medical specialists activities · NACE 8622
Est. 2022
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 2,6M
+14% vs 2024
EBITDA margin
25.6%
+1172% vs 2024
Equity ratio
68.1%
Financial strength
Net profit 2025
DKK 406K
+572% vs 2024
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
0M
2023
0M
0%
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
DKK 2,6M
+14%
EBITDA
DKK 670K
+1172%
Net profit
DKK 406K
+572%
Total assets
DKK 1,7M
+29%
Equity
DKK 1,2M
+54%
Employees
2
—
Company information
Legal name
Speciallæge Jette Labianca ApS
CVR number
43739875
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
30. december 2022
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af én direktør.
Company purpose
Virksomhedens formål er at udøve speciallægepraksis indenfor psykiatri og anden i forbindelse hermed stående virksomhed.
Contact
Address
Engelsborgvej 38, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Lyngby-Taarbæk
All Denmark companies
Revenue
DKK millions
0M
1M
2M
3M
3M
2M
2023
2M
2024
3M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
1M
2025
Income statement
DKK thousands
Item
2023
2024
2025
Revenue
2.207
2.307
2.619
Staff expenses
-2.194
-2.254
-1.949
EBITDA
13
53
670
Depreciation & amort.
-100
-100
-100
EBIT
-87
-47
570
Net financials
-31
-40
-34
Profit before tax
-118
-87
536
Tax
-22
-1
130
Net profit
-96
-86
406
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
1.412
1.320
1.699
Equity
837
751
1.157
Long-term debt
0
0
147
Short-term debt
377
393
240
Total debt
377
393
387
Financial ratios
5-year trend
EBITDA margin
25.6%
This company
15.8%
Market median
+62% vs market
2023
2025
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
2023
2025
Return on equity
35.1%
This company
18.4%
Market median
+91% vs market
2023
2025
Net profit margin
15.5%
This company
8.1%
Market median
+91% vs market
2023
2025
Asset turnover
1.54×
This company
1.12×
Market median
+37% vs market
2023
2025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Jette Labianca
Individual
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Speciallæge Jette Labianca ApS also hold positions in
0
other companies.
Person
Role here
Other companies